T45.625
Adverse effect of hemostatic drug
Clinical Classification Guidelines
Medical Intelligence & Overview
The ICD-10 code T45.625 pertains to adverse effects caused by hemostatic drugs. Hemostatic medications are commonly used to control bleeding during surgeries or in patients with bleeding disorders. While these drugs are generally effective and safe when used appropriately, some individuals may experience unwanted side effects or adverse reactions. Recognizing these effects is vital for healthcare providers to ensure timely management and to adjust treatment plans if necessary.
Causes & Symptoms
Clinical Causes: Incorrect dosage or overuse of hemostatic agents Allergic reactions to specific components within the medication Patient-specific factors such as genetic predispositions or underlying health conditions Drug interactions that enhance the risk of adverse effects Prolonged or inappropriate usage leading to toxicity
Key Symptoms: Local reactions such as redness, swelling, or pain at the injection or application site Systemic reactions including fever, chills, or rash Signs of hypersensitivity such as hives, itching, or difficulty breathing Unusual bleeding or clot formation Laboratory abnormalities indicating coagulation issues Nausea, vomiting, or abdominal discomfort in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a thorough review of the patient’s medical history, medication use, and presenting symptoms. Laboratory tests such as coagulation profiles, blood counts, and specific renal or hepatic function tests may be conducted to assess the extent of adverse effects. Imaging or other diagnostic procedures might be employed if complication suspicion arises. The healthcare provider must differentiate between expected drug reactions and more severe adverse effects requiring urgent intervention.
Treatment Protocols: Management of adverse effects related to hemostatic drugs depends on severity. Mild reactions may resolve with discontinuation of the medication and supportive care, including antihistamines or corticosteroids for allergic responses. Severe reactions might require hospitalization, specialized interventions, and alternative therapies. Monitoring and follow-up are essential to prevent recurrence or worsening of adverse effects. It is essential for healthcare providers to weigh the benefits and risks when prescribing these medications to minimize potential adverse outcomes.
Clinical Advice & FAQs
Billing Guidance
Is T45.625 a billable ICD-10 code?
Yes, T45.625 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T45.625?
Clinical documentation must specify the nature of Adverse effect of hemostatic drug and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
